FDA Limits Opioid Cough/Cold Meds to Protect Kids

FDA announced safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than age 18 years, saying the risks of the medicines outweigh their potential benefits.  Per FDA, After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older.  Labeling for the drugs is also being updated with additional safety information for adult use, including an expanded boxed warning, warning of the risks of misuse, abuse, addiction, overdose and death, and slowed or difficult breathing that can result from exposure to codeine or hydrocodone.